{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:15:01Z","timestamp":1794482101547,"version":"4.9.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T00:00:00Z","timestamp":1587427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1038\/s41577-020-0321-6","type":"journal-article","created":{"date-parts":[[2020,4,21]],"date-time":"2020-04-21T11:10:40Z","timestamp":1587467440000},"page":"339-341","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":453,"title":["The potential danger of suboptimal antibody responses in COVID-19"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7824-9856","authenticated-orcid":false,"given":"Akiko","family":"Iwasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yexin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,21]]},"reference":[{"key":"321_CR1","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jcv.2005.07.005","volume":"35","author":"N Lee","year":"2006","unstructured":"Lee, N. et al. Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome. J. Clin. Virol. 35, 179\u2013184 (2006).","journal-title":"J. Clin. Virol."},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1172\/JCI84428","volume":"126","author":"DJ DiLillo","year":"2016","unstructured":"DiLillo, D. J. et al. Broadly neutralizing anti-influenza antibodies require Fc receptor engagement for in vivo protection. J. Clin. Invest. 126, 605\u2013610 (2016).","journal-title":"J. Clin. Invest."},{"key":"321_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicro2090","volume":"7","author":"L Du","year":"2009","unstructured":"Du, L. et al. The spike protein of SARS-CoV \u2014 a target for vaccine and therapeutic development. Nat. Rev. Microbiol. 7, 226\u2013236 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.virol.2014.02.005","volume":"454","author":"F Yasui","year":"2014","unstructured":"Yasui, F. et al. Phagocytic cells contribute to the antibody-mediated elimination of pulmonary-infected SARS coronavirus. Virology 454, 157\u2013168 (2014).","journal-title":"Virology"},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbrc.2014.07.090","volume":"451","author":"SF Wang","year":"2014","unstructured":"Wang, S. F. et al. Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins. Biochem. Biophys. Res. Commun. 451, 208\u2013214 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"10582","DOI":"10.1128\/JVI.00671-11","volume":"85","author":"M Jaume","year":"2011","unstructured":"Jaume, M. et al. Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway. J. Virol. 85, 10582\u201310597 (2011).","journal-title":"J. Virol."},{"key":"321_CR7","first-page":"25","volume":"22","author":"MS Yip","year":"2016","unstructured":"Yip, M. S. et al. Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS. Hong Kong Med. J. 22, 25\u201331 (2016).","journal-title":"Hong Kong Med. J."},{"key":"321_CR8","doi-asserted-by":"publisher","first-page":"6337","DOI":"10.4049\/jimmunol.181.9.6337","volume":"181","author":"F Yasui","year":"2008","unstructured":"Yasui, F. et al. Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV. J. Immunol. 181, 6337\u20136348 (2008).","journal-title":"J. Immunol."},{"key":"321_CR9","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.123158","volume":"4","author":"L Liu","year":"2019","unstructured":"Liu, L. et al. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection. JCI Insight 4, e123158 (2019).","journal-title":"JCI Insight"},{"key":"321_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1021\/acsinfecdis.6b00006","volume":"2","author":"Q Wang","year":"2016","unstructured":"Wang, Q. et al. Immunodominant SARS coronavirus epitopes in humans elicited both enhancing and neutralizing effects on infection in non-human primates. ACS Infect. Dis. 2, 361\u2013376 (2016).","journal-title":"ACS Infect. Dis."},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.chom.2008.08.004","volume":"4","author":"TC Pierson","year":"2008","unstructured":"Pierson, T. C. et al. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4, 229\u2013238 (2008).","journal-title":"Cell Host Microbe"},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1399-0039.2005.00476.x","volume":"66","author":"FF Yuan","year":"2005","unstructured":"Yuan, F. F. et al. Influence of Fc\u03b3RIIA and MBL polymorphisms on severe acute respiratory syndrome. Tissue Antigens 66, 291\u2013296 (2005).","journal-title":"Tissue Antigens"},{"key":"321_CR13","doi-asserted-by":"publisher","first-page":"12201","DOI":"10.1128\/JVI.06048-11","volume":"85","author":"M Bolles","year":"2011","unstructured":"Bolles, M. et al. A double-inactivated severe acute respiratory syndrome coronavirus vaccine provides incomplete protection in mice and induces increased eosinophilic proinflammatory pulmonary response upon challenge. J. Virol. 85, 12201\u201312215 (2011).","journal-title":"J. Virol."},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1073\/pnas.0409065102","volume":"102","author":"Z-y Yang","year":"2005","unstructured":"Yang, Z.-y. et al. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc. Natl Acad. Sci. USA 102, 797 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"321_CR15","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/nm.2972","volume":"18","author":"RL Graham","year":"2012","unstructured":"Graham, R. L. et al. A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat. Med. 18, 1820\u20131826 (2012).","journal-title":"Nat. Med."},{"key":"321_CR16","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.24.20042382","author":"W Tan","year":"2020","unstructured":"Tan, W. et al. Viral kinetics and antibody responses in patients with COVID-19. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.03.24.20042382 (2020).","journal-title":"medRxiv"},{"key":"321_CR17","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.20.20039495","author":"H-w Jiang","year":"2020","unstructured":"Jiang, H.-w. et al. Global profiling of SARS-CoV-2 specific IgG\/IgM responses of convalescents using a proteome microarray. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.03.20.20039495 (2020).","journal-title":"medRxiv"},{"key":"321_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.30.20047365","author":"F Wu","year":"2020","unstructured":"Wu, F. et al. Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.03.30.20047365 (2020).","journal-title":"medRxiv"}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0321-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0321-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41577-020-0321-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:59:37Z","timestamp":1684605577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-0321-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,21]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1038\/s41577-020-0321-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.737790348.793577199","asserted-by":"object"}]},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"value":"1474-1733","type":"print"},{"value":"1474-1741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,21]]},"assertion":[{"value":"21 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}